JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) — Cash Flow Reinvestment Rate

Latest as of December 2025: 13.41x

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) has a Cash Flow Reinvestment Rate of 13.41x as of December 2025, reinvesting $4.58 Million (capex $4.58 Million ) from operating cash flow of $341.55K. See JIN MEDICAL INTERNATIONAL LTD. Ordinary (ZJYL) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

13.41x
(Capex + Investments) / Operating CF

Total Reinvested

$4.58 Million
Capex + Investments

Operating Cash Flow

$341.55K
USD

Capital Expenditures

$4.58 Million
USD

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Cash Flow Reinvestment Rate (2020–2025)

Historical reinvestment intensity for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares across 5 annual periods. For the full cash flow conversion analysis, see ZJYL cash flow conversion.

Annual Cash Flow Reinvestment Rate for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2020–2025)

Year-by-year capital reinvestment analysis for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares. See ZJYL financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 3.54x $10.29 Million $2.90 Million $6.63 Million ▲ +42.3%
2023 2.49x $7.74 Million $3.11 Million $113.94K ▲ +2345.3%
2022 0.10x $161.07K $1.58 Million $40.17K ▼ -46.4%
2021 0.19x $1.11 Million $5.84 Million $42.88K ▼ -77.4%
2020 0.84x $2.10 Million $2.50 Million $142.32K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow